Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome

OBJECTIVE: We report an outbreak of Achromobacter xylosoxidans at a neonatal intensive care unit. We aimed to present clinical, laboratory and treatment data of the patients. Materials and METHODS: All consecutive episodes of bacteremia due to A. xylosoxidans at our neonatal intensive care unit, beg...

Full description

Bibliographic Details
Main Authors: Ozden Turel, Sultan Kavuncuoglu, Emine Hosaf, Sibel Ozbek, Esin Aldemir, Turkan Uygur, Nevin Hatipoglu, Rengin Siraneci
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000400011&lng=en&tlng=en
_version_ 1818455206989398016
author Ozden Turel
Sultan Kavuncuoglu
Emine Hosaf
Sibel Ozbek
Esin Aldemir
Turkan Uygur
Nevin Hatipoglu
Rengin Siraneci
author_facet Ozden Turel
Sultan Kavuncuoglu
Emine Hosaf
Sibel Ozbek
Esin Aldemir
Turkan Uygur
Nevin Hatipoglu
Rengin Siraneci
author_sort Ozden Turel
collection DOAJ
description OBJECTIVE: We report an outbreak of Achromobacter xylosoxidans at a neonatal intensive care unit. We aimed to present clinical, laboratory and treatment data of the patients. Materials and METHODS: All consecutive episodes of bacteremia due to A. xylosoxidans at our neonatal intensive care unit, beginning with the index case detected at November 2009 until cessation of the outbreak in April 2010, were evaluated retrospectively. RESULTS: Thirty-four episodes of bacteremia occurred in 22 neonates during a 6-month period. Among the affected, 90% were preterm newborns with gestational age of 32 weeks or less and 60% had birth weight of 1000 g or less. Endotracheal intubation, intravenous catheter use, total parenteral nutrition and prolonged antibiotic therapy were the predisposing conditions. Presenting features were abdominal distention, thrombocytopenia and neutropenia. The mortality rate was 13.6% and the majority of isolates were susceptible to piperacillin-tazobactam, carbapenems and trimethoprim-sulfametoxazole, and resistant to gentamycin. More than half were breakthrough infections. Despite intensive efforts to control the outbreak by standard methods of hand hygiene, patient screening and isolation, containment could be achieved only after the neonatal intensive care unit was relocated. The investigation was not able to single out the source of the outbreak. CONCLUSION: A. xylosoxidans has the potential to cause serious infections in premature babies. More studies are needed to determine the importance of different sources of infection in hospital units.
first_indexed 2024-12-14T22:07:06Z
format Article
id doaj.art-c5952c9ca92f4c5f95174349e66b2f71
institution Directory Open Access Journal
issn 1678-4391
language English
last_indexed 2024-12-14T22:07:06Z
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-c5952c9ca92f4c5f95174349e66b2f712022-12-21T22:45:50ZengElsevierBrazilian Journal of Infectious Diseases1678-439117445045410.1016/j.bjid.2013.01.008S1413-86702013000400011Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcomeOzden Turel0Sultan Kavuncuoglu1Emine Hosaf2Sibel Ozbek3Esin Aldemir4Turkan Uygur5Nevin Hatipoglu6Rengin Siraneci7Bezmialem Vakif UniversityKanuni Sultan Süleyman Training and Research HospitalKanuni Sultan Süleyman Training and Research HospitalKanuni Sultan Süleyman Training and Research HospitalKanuni Sultan Süleyman Training and Research HospitalKanuni Sultan Süleyman Training and Research HospitalKanuni Sultan Süleyman Training and Research HospitalBezmialem Vakif UniversityOBJECTIVE: We report an outbreak of Achromobacter xylosoxidans at a neonatal intensive care unit. We aimed to present clinical, laboratory and treatment data of the patients. Materials and METHODS: All consecutive episodes of bacteremia due to A. xylosoxidans at our neonatal intensive care unit, beginning with the index case detected at November 2009 until cessation of the outbreak in April 2010, were evaluated retrospectively. RESULTS: Thirty-four episodes of bacteremia occurred in 22 neonates during a 6-month period. Among the affected, 90% were preterm newborns with gestational age of 32 weeks or less and 60% had birth weight of 1000 g or less. Endotracheal intubation, intravenous catheter use, total parenteral nutrition and prolonged antibiotic therapy were the predisposing conditions. Presenting features were abdominal distention, thrombocytopenia and neutropenia. The mortality rate was 13.6% and the majority of isolates were susceptible to piperacillin-tazobactam, carbapenems and trimethoprim-sulfametoxazole, and resistant to gentamycin. More than half were breakthrough infections. Despite intensive efforts to control the outbreak by standard methods of hand hygiene, patient screening and isolation, containment could be achieved only after the neonatal intensive care unit was relocated. The investigation was not able to single out the source of the outbreak. CONCLUSION: A. xylosoxidans has the potential to cause serious infections in premature babies. More studies are needed to determine the importance of different sources of infection in hospital units.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000400011&lng=en&tlng=enAchromobacter xylosoxidansBloodstream infectionNeonate
spellingShingle Ozden Turel
Sultan Kavuncuoglu
Emine Hosaf
Sibel Ozbek
Esin Aldemir
Turkan Uygur
Nevin Hatipoglu
Rengin Siraneci
Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
Brazilian Journal of Infectious Diseases
Achromobacter xylosoxidans
Bloodstream infection
Neonate
title Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_full Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_fullStr Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_full_unstemmed Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_short Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
title_sort bacteremia due to achromobacter xylosoxidans in neonates clinical features and outcome
topic Achromobacter xylosoxidans
Bloodstream infection
Neonate
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000400011&lng=en&tlng=en
work_keys_str_mv AT ozdenturel bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT sultankavuncuoglu bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT eminehosaf bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT sibelozbek bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT esinaldemir bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT turkanuygur bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT nevinhatipoglu bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome
AT renginsiraneci bacteremiaduetoachromobacterxylosoxidansinneonatesclinicalfeaturesandoutcome